CUPERTINO, Calif., May 1 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present at the 2007 UBS Global
Generic and Specialty Pharmaceuticals Conference being held at the
Grand Hyatt Hotel in New York City. Matthew J. Hogan, Chief Financial
Officer, will be presenting at the conference on May 8th at 2:30 p.m. Eastern
Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )
To access the audio webcast: Go to www.ibb.ubs.com. Find the Conference
link in the middle of the page. Click on the link. Look for the “Webcast”
link under the 2007 Global Generic and Specialty Pharmaceuticals Conference.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit
www.www.durect.com.
SOURCE DURECT Corporation
05/01/2007
CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT
Corporation, +1-408-777-4936; or media, Jeremiah Hall, Senior Vice President
of Feinstein Kean Healthcare, +1-415 677-2700, or jeremiah.hall@fkhealth.com,
for DURECT Corporation
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.www.durect.com
(DRRX)